Pharmasaga Co. Ltd. (TPEX:7878)
Taiwan
· Delayed Price · Currency is TWD 307.50
+18.50 (6.40%)
At close: Feb 26, 2026
Pharmasaga Statistics
Total Valuation
Pharmasaga has a market cap or net worth of TWD 17.16 billion. The enterprise value is 16.60 billion.
| Market Cap | 17.16B |
| Enterprise Value | 16.60B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Pharmasaga has 53.54 million shares outstanding. The number of shares has increased by 63.10% in one year.
| Current Share Class | 53.54M |
| Shares Outstanding | 53.54M |
| Shares Change (YoY) | +63.10% |
| Shares Change (QoQ) | +193.66% |
| Owned by Insiders (%) | 17.50% |
| Owned by Institutions (%) | 7.26% |
| Float | 42.06M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 26.55 |
| P/TBV Ratio | 29.87 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -189.58 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -216.25 |
Financial Position
The company has a current ratio of 44.29, with a Debt / Equity ratio of 0.01.
| Current Ratio | 44.29 |
| Quick Ratio | 43.89 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.05 |
| Interest Coverage | -1,526.95 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -15.05% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -7.96M |
| Employee Count | 9 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 278.43 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 59.82 |
| Average Volume (20 Days) | 392,430 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -97.73M |
| Pretax Income | -87.57M |
| Net Income | -87.57M |
| EBITDA | -90.66M |
| EBIT | -97.73M |
| Earnings Per Share (EPS) | -2.78 |
Balance Sheet
The company has 561.05 million in cash and 3.49 million in debt, giving a net cash position of 557.57 million or 10.41 per share.
| Cash & Cash Equivalents | 561.05M |
| Total Debt | 3.49M |
| Net Cash | 557.57M |
| Net Cash Per Share | 10.41 |
| Equity (Book Value) | 646.35M |
| Book Value Per Share | 18.10 |
| Working Capital | 555.30M |
Cash Flow
In the last 12 months, operating cash flow was -75.34 million and capital expenditures -1.43 million, giving a free cash flow of -76.77 million.
| Operating Cash Flow | -75.34M |
| Capital Expenditures | -1.43M |
| Free Cash Flow | -76.77M |
| FCF Per Share | -1.43 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Pharmasaga does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -63.10% |
| Shareholder Yield | -63.10% |
| Earnings Yield | -0.51% |
| FCF Yield | -0.45% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |